Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Maxcyte, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- −4 vs. Q3 2022
- Shares held
- 69.3M
- −563.5K (−0.8%) vs. Q3 2022
- Total value
- $377.7M
- −$76.1M (−16.8%) vs. Q3 2022
- New holders
- 7
- 47 more added
- Sold out
- 11
- 29 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Blue Water Life Science Advisors, LLC | 3,225,000 | $17.6M | 11.83% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,848,117 | $26.5M | 0.00% | +182,797+3.9% | Added |
| Vitruvian Partners LLP | 5,043,356 | $27.5M | 5.80% | 00.0% | Unchanged |
| BlackRock Inc. | 6,815,082 | $37.2M | 0.00% | +367,139+5.7% | Added |
| Casdin Capital, LLC | 9,505,000 | $51.9M | 4.05% | −1,230,786−11.5% | Reduced |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −156,158−100.0% | Sold out |
| Harbert Fund Advisors, Inc. | 0 | $0 | 0.00% | −98,304−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −54,081−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −13,220−100.0% | Sold out |
| Freemont Management S.A. | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,055−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3,448−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −664−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −362−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −48−100.0% | Sold out |